I'm interested in conversations about and I want to talk about
Know exactly what you want?
Show search

Notification

Error

Trial suggests no need for H/T with R/T for low grade Pca

Email this conversation Print this conversation
User
Posted 27 May 2024 at 11:53
User
Posted 28 May 2024 at 11:02

Thanks Adrian. A lot of these studies also provide useful background information. For example 52300 diagnosis per year, I was working on an assumption of 40000. The number of prostatectomies 7000 I had assumed 9000 and the failure rate of prostatectomy which is 2000 a little less than 30%.


A shame they didn't break the remainder down in to RT per year and AS per year.


I would say the 80% survival is good but the fact it was only 72% met free survival is a little more worrying. Particularly as this is ten year survival, and for me diagnosed at 53 I am interested in the 30 year survival.

Dave

User
Posted 28 May 2024 at 22:23
Dave, the trouble is that any 30 year survival data will relate to the standard treatments in the early 1990s, not massively relevant to decision-making by those facing treatment in 2024.

Certainly radiotherapy technology has advanced massively, and most surgery is now robotic. Hormone treatments have probably evolved, chemotherapy definitely has.
Show Most Thanked Posts
User
Posted 28 May 2024 at 11:02

Thanks Adrian. A lot of these studies also provide useful background information. For example 52300 diagnosis per year, I was working on an assumption of 40000. The number of prostatectomies 7000 I had assumed 9000 and the failure rate of prostatectomy which is 2000 a little less than 30%.


A shame they didn't break the remainder down in to RT per year and AS per year.


I would say the 80% survival is good but the fact it was only 72% met free survival is a little more worrying. Particularly as this is ten year survival, and for me diagnosed at 53 I am interested in the 30 year survival.

Dave

User
Posted 28 May 2024 at 22:23
Dave, the trouble is that any 30 year survival data will relate to the standard treatments in the early 1990s, not massively relevant to decision-making by those facing treatment in 2024.

Certainly radiotherapy technology has advanced massively, and most surgery is now robotic. Hormone treatments have probably evolved, chemotherapy definitely has.
 
Forum Jump  
Email this conversation Print this conversation

Join the online community now.

Click through to become a member and gain access to support, information and real time replies.




MenuTop ▲
©2024 Prostate Cancer UK